A new study suggests semaglutide, a medication for obesity/diabetes, might reduce cannabis use in patients
In fact, the opposite may be true
The SUSTAIN 6 trial also included approximately equal numbers of subjects from each renal impairment group (including subjects with normal renal function), and a possible trial effect should therefore not exclusively affect the severe renal impairment covariate
Does semaglutide work for people without much weight to lose
Semaglutide has a black box warning from the FDA for the risk of thyroid tumors or medullary thyroid carcinoma (MTC)
For most patients, reaching goal weight does not signal the end of treatment but rather a transition from the weight loss phase to the weight maintenance phase, which typically requires continued pharmacological support for optimal outcomes as long as benefits outweigh risks